CAS 1370261-97-4

P505-15 Hydrochloride

Description:

P505-15 Hydrochloride, identified by its CAS number 1370261-97-4, is a chemical compound that belongs to a class of substances known for their potential applications in various fields, including pharmaceuticals and biochemistry. While specific characteristics such as molecular weight, solubility, and melting point may vary, compounds of this nature typically exhibit properties such as being hygroscopic and soluble in water, which can influence their stability and reactivity. The hydrochloride form often enhances the compound's solubility and bioavailability, making it more effective for therapeutic uses. Additionally, P505-15 Hydrochloride may possess specific functional groups that contribute to its biological activity, potentially interacting with various biological targets. As with any chemical substance, safety data sheets and handling guidelines should be consulted to ensure proper safety measures are taken during its use. Further research and characterization studies would provide more detailed insights into its specific properties and applications.

Formula: C₁₉H₂₄ClN₉O

InChI: InChI=1S/C19H23N9O.ClH/c20-15-6-1-2-7-16(15)26-19-22-11-14(17(21)29)18(27-19)25-12-4-3-5-13(10-12)28-23-8-9-24-28;/h3-5,8-11,15-16H,1-2,6-7,20H2,(H2,21,29)(H2,22,25,26,27);1H/t15-,16+;/m0./s1

InChI key: InChIKey=RMNLLPXCNDZJMJ-IDVLALEDSA-N

SMILES: N(C=1C(C(N)=O)=CN=C(N[C@H]2[C@@H](N)CCCC2)N1)C3=CC(=CC=C3)N4N=CC=N4.Cl

Synonyms:

• 2-[[(1R,2S)-2-Aminocyclohexyl]amino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]amino]-5-pyrimidinecarboxamide Hydrochloride
• 2-{[(1R,2R)-2-Aminocyclohexyl]amino}-4-{[3-(2H-1,2,3-triazol-2-yl )phenyl]amino}-5-pyrimidinecarboxamide hydrochloride (1:1)
• 4-(3-(2H-1,2,3-triazol-2-yl)phenylamino)-2-((1R,2S)-2-aminocyclohexylamino)pyrimidin-5-carboxamide hydrochloride
• 4-(3-([1,1'-Biphenyl-4-Yl])-3-Oxopropyl)Benzonitrile
• 5-Pyrimidinecarboxamide, 2-[[(1R,2S)-2-aminocyclohexyl]amino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]amino]-, hydrochloride (1:1)
• Benzonitrile,4-(3-[1,1'-biphenyl]-4-yl-3-oxopropyl)
• P505-15, BIIB057 HCl, PRT062607(HCL)
• PRT062607(Hydrochloride)
• BIIB 057 HCl
• PRT 062607 HCl
• P 505-15 HCl
• PRT062607 (P505-15, BIIB057) HCl
• PRT062607 (Hydrochloride) USP/EP/BP
• CS-995
• P505-15 HCl salt, PRT062607 HCl salt,PRT-2607 HCl salt, BIIB-057 HCl salt
• 4-((4-(2H-1,2,3-Triazol-2-yl)phenyl)amino)-2-(((1R,2S)-2-aminocyclohexyl)amino)pyrimidine-5-carboxamide hydrochloride
• BIIB057 HCl
• P505-15; PRT2607; PRT-2607; PRT 2607; PRT-062607; PRT 062607; P505-15; BIIB057
• PRT062607 (P505-15, BIIB057) hydrochloride
• P505-15 hydrochloride
• 4-((4-(2H-1,2,3-Triazol-2-yl)phenyl)amino)-2-(((1R,2S)-2-aminocyclohexyl)amino)pyrimidine-5-ca
• PRT-2607 HCl
• 2-[[(1R,2S)-2-Aminocyclohexyl]amino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]amino]-5-pyrimidinecarboxamide hydrochloride (1:1)
• PRT062607 (P505-15 HCL)
• PRT062607 HCL

Prt062607 hcl

CAS: 1370261-97-4

Formula: C₁₉H₂₄ClN₉O

Purity: 98%

Color and Shape: Solid

Molecular weight: 429.9066

Ref: IN-DA0012PY

4-((3-(2H-1,2,3-Triazol-2-Yl)Phenyl)Amino)-2-(((1R,2S)-2-Aminocyclohexyl)Amino)Pyrimidine-5-Carboxamide Hydrochloride

CAS: 1370261-97-4

4-((3-(2H-1,2,3-Triazol-2-Yl)Phenyl)Amino)-2-(((1R,2S)-2-Aminocyclohexyl)Amino)Pyrimidine-5-Carboxamide Hydrochloride

Purity: 98%

Molecular weight: 429.91g/mol

Ref: 54-OR1023113

PRT062607 hydrochloride

CAS: 1370261-97-4

PRT062607 hydrochloride

Purity: ≥95%

Molecular weight: 429.91g/mol

Ref: 54-BUP07820

PRT062607 hydrochloride

CAS: 1370261-97-4

PRT062607 hydrochloride (P505-15 Hydrochloride) is a selective inhibitor of Syk. PRT062607 displays at least 80-fold selectivity for Syk over other kinases.

Formula: C₁₉H₂₃N₉O·HCl

Purity: 97.7% - 99.81%

Color and Shape: Solid

Molecular weight: 429.91

Ref: TM-T2696

PRT062607 hydrochloride

CAS: 1370261-97-4

Purity: ≥98%

Molecular weight: 429.179

Ref: 10-F861760

PRT062607 (P505-15) HCl

CAS: 1370261-97-4

PRT062607 (P505-15) HCl is a small-molecule inhibitor, which is a synthetic compound with a highly specific action on the 3-phosphoinositide-dependent protein kinase-1 (PDK1). This compound is derived through rational drug design processes aimed at modulating intracellular signaling pathways. PRT062607 acts by selectively binding to the ATP-binding site of PDK1, thereby inhibiting its kinase activity. This inhibition disrupts downstream signaling mediated by the phosphoinositide 3-kinase (PI3K) pathway, which is pivotal in regulating various cellular processes, including growth, survival, and metabolism.

Formula: C₁₉H₂₃N₉O·HCl

Purity: Min. 95%

Molecular weight: 429.91 g/mol

Ref: 3D-VEC26197